Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey.


Creative Commons License

KILIÇKAP S., Öztürk A., KARADURMUŞ N., KORKMAZ T., YUMUK P. F., ÇİÇİN İ., ...More

IASLC 19th World Conference On Lung Cancer, Canada, 23 - 26 September 2018, vol.13, pp.1020, (Full Text)